We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+0.51%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$11.2B
AUM Growth
-$244M
Cap. Flow
-$183M
Cap. Flow %
-1.64%
Top 10 Hldgs %
22.89%
Holding
2,613
New
177
Increased
266
Reduced
1,243
Closed
46

Sector Composition

Rank Sector Weight
1 Technology 21.19%
2 Financials 13.17%
3 Healthcare 12.67%
4 Consumer Discretionary 11.48%
5 Industrials 8.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SENEA icon
2376
Seneca Foods Class A
SENEA
$1.28B
$115K ﹤0.01%
+2,395
New +$121K
PFIS icon
2377
Peoples Financial Services
PFIS
$714M
$115K ﹤0.01%
+2,533
New +$113K
SFT
2378
DELISTED
Shift Technologies, Inc. Class A Common Stock
SFT
$115K ﹤0.01%
1,656
-1,031
-38% -$82.6K
JANX icon
2379
Janux Therapeutics
JANX
$1.02B
$115K ﹤0.01%
+5,302
New +$153K
LE icon
2380
Lands' End
LE
$391M
$114K ﹤0.01%
4,859
SSTI icon
2381
SoundThinking
SSTI
$106M
$114K ﹤0.01%
3,138
DAWN
2382
DELISTED
Day One Biopharmaceuticals
DAWN
$114K ﹤0.01%
+4,806
New +$115K
MCF
2383
DELISTED
Contango Oil & Gas Co.
MCF
$114K ﹤0.01%
24,955
-21,219
-46% -$80.8K
PLSE icon
2384
Pulse Biosciences
PLSE
$3.09B
$114K ﹤0.01%
+5,276
New +$114K
CNBKA
2385
DELISTED
Century Bancorp Inc/Mass
CNBKA
$114K ﹤0.01%
+986
New +$113K
CTO
2386
CTO Realty Growth
CTO
$819M
$113K ﹤0.01%
+6,327
New +$115K
INFI
2387
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$113K ﹤0.01%
+33,123
New +$102K
LITS
2388
Lite Strategy Inc
LITS
$31.4M
$113K ﹤0.01%
2,049
+1,474
+256% +$81.1K
IEA
2389
DELISTED
Infrastructure and Energy Alternatives, Inc. Common Stock
IEA
$113K ﹤0.01%
+9,886
New +$121K
CIA icon
2390
Citizens
CIA
$199M
$113K ﹤0.01%
+18,124
New +$103K
LENZ
2391
LENZ Therapeutics
LENZ
$158M
$112K ﹤0.01%
+980
New +$145K
STXB
2392
DELISTED
Spirit of Texas Bancshares, Inc. Common Stock
STXB
$112K ﹤0.01%
+4,640
New +$107K
GRTS
2393
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$112K ﹤0.01%
10,389
-6,065
-37% -$55.2K
KZR
2394
DELISTED
Kezar Life Sciences
KZR
$112K ﹤0.01%
+1,294
New +$85.6K
CDAK
2395
DELISTED
Codiak BioSciences, Inc. Common Stock
CDAK
$111K ﹤0.01%
+6,809
New +$122K
INDT
2396
DELISTED
INDUS Realty Trust, Inc. (MD) Common Stock
INDT
$111K ﹤0.01%
+1,581
New +$108K
FLXN
2397
DELISTED
Flexion Therapeutics, Inc.
FLXN
$111K ﹤0.01%
18,164
+12,336
+212% +$76.9K
IPI icon
2398
Intrepid Potash
IPI
$490M
$110K ﹤0.01%
+3,574
New +$112K
TCS
2399
DELISTED
THE CONTAINER STORE GROUP, INC.
TCS
$110K ﹤0.01%
773
+563
+268% +$94.4K
DRRX
2400
DELISTED
DURECT Corp
DRRX
$110K ﹤0.01%
8,618
+6,165
+251% +$83.6K

Similar funds

MetLife Investment Management's Q3 2021 Portfolio in Review

As of Q3 2021, MetLife Investment Management held 2,613 positions worth $11.2B, down 2.1% from $11.4B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

MetLife Investment Management's Q3 2021 filing shows 177 new, 266 increased, 1,243 reduced and 46 closed positions. Its largest new stake was Moderna: 79,316 shares worth $30.5M. The largest sale was Energy Transfer Partners, an estimated $35.7M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.

  • MetLife Investment Management's largest Q3 2021 buy was Moderna: 79,316 shares worth $30.5M.
  • MetLife Investment Management added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $39.7M increase.
  • MetLife Investment Management's biggest Q3 2021 reduction was Energy Transfer Partners, cutting an estimated $35.7M.
  • MetLife Investment Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $9.28M.
  • MetLife Investment Management's ten largest holdings make up 23% of its $11.2B portfolio in Q3 2021.
  • MetLife Investment Management opened 177 new positions and closed 46 in Q3 2021.
  • MetLife Investment Management's portfolio value fell 2.1% quarter-over-quarter to $11.2B.

Based on MetLife Investment Management's 13F filing for Q3 2021, filed 15 Nov 2021.